Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Ausztria
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
- Where
- Graz, Leoben, Linz, Vienna, Wels
- Életkor
- 18 év and over
- People
- 904 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06091865 · EU 2022-502785-25-00 - 3. fázisTaking peopleAge-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – a randomized phase III trial - PRIMA-CNS
- Where
- Graz, Innsbruck, Linz
- Életkor
- 65 év and over
- People
- 260 worldwide
- Run by
- Medical Center - University Of Freiburg
See details and how to join2024-512320-11-00 · EU 2024-512320-11-00 - 2. fázisTaking peopleEfficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
- Where
- Graz, Innsbruck, Linz, Vienna
- Életkor
- 18 év to 70 év
- People
- 213 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT04844866 · EU 2023-506270-13-00 - No phaseTaking peopleReal-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
- Where
- Graz, Leoben
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- AbbVie
See details and how to joinNCT06830759 - Korai 1. fázisNot yet taking people in AusztriaImmunoMRI for Assessment of Tumor-associated Macrophages
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 60
- Run by
- Medical University of Vienna
See details and how to joinNCT07066436